Abstract:Purpose/Objective(s)To assess the PTV margin reduction due to the use of diagnostic-quality, high-soft-tissue contrast, CT for treatment delivery guidance in prostate radiotherapy and the dosimetry gains with the reduced PTV margin.Materials/MethodsPTV margins for prostate were estimated to account for the residual interfraction errors and intrafraction prostate motion during the process of prostate radiotherapy with diagnostic-quality CT guidance to correct for interfraction set-up uncertainties and organ motion and deformation. The residual interfraction errors, including errors from the inter- and intra-observer variations in prostate registration and the isocenter alignment, were estimated based on the manual registration of a representative daily scan acquired on a CT-on-Rails (CTVision, Siemens) with its corresponding planning CT scan by 4 physicists and 16 therapists in Adaptive Targeting (Siemens) and on repeated registrations for the same representative scans over the span of three weeks by 1 physicist, respectively. The intrafraction prostate motion in a typical 10-15 minutes treatment was estimated to be 2 mm (SD) based on the previous studies. The van Herk margin recipe of 2.5 times the total systematic error plus 0.7 times the total random error was used. Dosimetric gains as a result of margin reduction were evaluated in terms of improved normal tissue sparing or safe dose escalation for prostate based on sample patient plans using the Prowess planning system.ResultsThe inter- and intra-observer variations in registering prostate from daily CT to the planning CT were estimated to be 1 mm (SD). The isocenter alignment error contains a random error of 0.5 mm (SD) and a systematic error of 0.5 mm (SD). The PTV margin was estimated to be 2.8 mm. Plans generated with 3 mm uniform margin and same prescription dose show a 7% or 5% reduction in rectal and bladder mean dose, respectively, for the plans generated with a uniform margin of 5 mm or a margin of 5 mm in all directions except 3 mm posteriorly. If keeping the doses to normal structures unchanged, the uniform 3 mm margin would allow 11% or 9% dose escalation for the prostate, respectively, from that for the uniform 5 mm or non-uniform 5-3 mm margins.ConclusionsThe PTV margin for prostate RT can be reduced to a uniform margin of 3 mm if each treatment is guided by diagnostic quality CT. Such a small margin allows the dose to the prostate to be safely escalated by 10% from those with the margins used commonly in the current standard practice of IGRT. Purpose/Objective(s)To assess the PTV margin reduction due to the use of diagnostic-quality, high-soft-tissue contrast, CT for treatment delivery guidance in prostate radiotherapy and the dosimetry gains with the reduced PTV margin. To assess the PTV margin reduction due to the use of diagnostic-quality, high-soft-tissue contrast, CT for treatment delivery guidance in prostate radiotherapy and the dosimetry gains with the reduced PTV margin. Materials/MethodsPTV margins for prostate were estimated to account for the residual interfraction errors and intrafraction prostate motion during the process of prostate radiotherapy with diagnostic-quality CT guidance to correct for interfraction set-up uncertainties and organ motion and deformation. The residual interfraction errors, including errors from the inter- and intra-observer variations in prostate registration and the isocenter alignment, were estimated based on the manual registration of a representative daily scan acquired on a CT-on-Rails (CTVision, Siemens) with its corresponding planning CT scan by 4 physicists and 16 therapists in Adaptive Targeting (Siemens) and on repeated registrations for the same representative scans over the span of three weeks by 1 physicist, respectively. The intrafraction prostate motion in a typical 10-15 minutes treatment was estimated to be 2 mm (SD) based on the previous studies. The van Herk margin recipe of 2.5 times the total systematic error plus 0.7 times the total random error was used. Dosimetric gains as a result of margin reduction were evaluated in terms of improved normal tissue sparing or safe dose escalation for prostate based on sample patient plans using the Prowess planning system. PTV margins for prostate were estimated to account for the residual interfraction errors and intrafraction prostate motion during the process of prostate radiotherapy with diagnostic-quality CT guidance to correct for interfraction set-up uncertainties and organ motion and deformation. The residual interfraction errors, including errors from the inter- and intra-observer variations in prostate registration and the isocenter alignment, were estimated based on the manual registration of a representative daily scan acquired on a CT-on-Rails (CTVision, Siemens) with its corresponding planning CT scan by 4 physicists and 16 therapists in Adaptive Targeting (Siemens) and on repeated registrations for the same representative scans over the span of three weeks by 1 physicist, respectively. The intrafraction prostate motion in a typical 10-15 minutes treatment was estimated to be 2 mm (SD) based on the previous studies. The van Herk margin recipe of 2.5 times the total systematic error plus 0.7 times the total random error was used. Dosimetric gains as a result of margin reduction were evaluated in terms of improved normal tissue sparing or safe dose escalation for prostate based on sample patient plans using the Prowess planning system. ResultsThe inter- and intra-observer variations in registering prostate from daily CT to the planning CT were estimated to be 1 mm (SD). The isocenter alignment error contains a random error of 0.5 mm (SD) and a systematic error of 0.5 mm (SD). The PTV margin was estimated to be 2.8 mm. Plans generated with 3 mm uniform margin and same prescription dose show a 7% or 5% reduction in rectal and bladder mean dose, respectively, for the plans generated with a uniform margin of 5 mm or a margin of 5 mm in all directions except 3 mm posteriorly. If keeping the doses to normal structures unchanged, the uniform 3 mm margin would allow 11% or 9% dose escalation for the prostate, respectively, from that for the uniform 5 mm or non-uniform 5-3 mm margins. The inter- and intra-observer variations in registering prostate from daily CT to the planning CT were estimated to be 1 mm (SD). The isocenter alignment error contains a random error of 0.5 mm (SD) and a systematic error of 0.5 mm (SD). The PTV margin was estimated to be 2.8 mm. Plans generated with 3 mm uniform margin and same prescription dose show a 7% or 5% reduction in rectal and bladder mean dose, respectively, for the plans generated with a uniform margin of 5 mm or a margin of 5 mm in all directions except 3 mm posteriorly. If keeping the doses to normal structures unchanged, the uniform 3 mm margin would allow 11% or 9% dose escalation for the prostate, respectively, from that for the uniform 5 mm or non-uniform 5-3 mm margins. ConclusionsThe PTV margin for prostate RT can be reduced to a uniform margin of 3 mm if each treatment is guided by diagnostic quality CT. Such a small margin allows the dose to the prostate to be safely escalated by 10% from those with the margins used commonly in the current standard practice of IGRT. The PTV margin for prostate RT can be reduced to a uniform margin of 3 mm if each treatment is guided by diagnostic quality CT. Such a small margin allows the dose to the prostate to be safely escalated by 10% from those with the margins used commonly in the current standard practice of IGRT.

Planning Target Volume Margin Definition from Image Guided Hypofractionated Radiation Therapy for Pancreatic Cancer

Impact Of Interfractional Motion On Hypofractionated Pencil Beam Scanning Proton Therapy And Vmat Delivery For Prostate Cancer

The Effect Of Image-Guided Radiation Therapy On The Margin Between The Clinical Target Volume And Planning Target Volume In Lung Cancer

Evaluation Of The Dosimetric Impact Of Interfractional Anatomical Variations On Prostate Proton Therapy Using Daily In-Room Ct Images

Optimising PTV margins in oesophageal cancer radiotherapy: A modern radiotherapy planning, treatment delivery and verification approach – A single institutional analysis

Variation in target volume and position in concurrent chemoradiotherapy for pancreatic cancer

Advantages Of Diagnostic Quality Ct Guided Radiotherapy For Prostate Cancer: Margin Reduction And Dose Escalation

Characterizing Compromised Target Coverage With Hypofractionated Radiation Therapy for Pancreatic Cancer

Effect of Abdominal Compression on Target Movement and Extension of the External Boundary of Peripheral Lung Tumours Treated with Stereotactic Radiotherapy Based on Four-Dimensional Computed Tomography

Assessing target localization accuracy across different soft-tissue matching protocols using end-exhalation breath-hold cone-beam computed tomography in patients with pancreatic cancer

Planning target volume margin in head and neck cancer patients undergoing radiation therapy: Estimations derived from own data and literature

Characterization and Management of Interfractional Anatomic Changes for Pancreatic Cancer Radiotherapy

A Comparison of Planning Target Volume Definition by the Patient-Specific Margins and the Generic Margins for Thoracic Esophageal Cancer.

SU-FF-T-69: Determining Patient Eligibility for Prostate IMRT Dose Painting Protocols: The Role of Image Resolution, Margin Requirements, and Intraprostatic Tumor Volume

Inter- and intrafractional setup errors and baseline shifts of fiducial markers in patients with liver tumors receiving free-breathing postoperative radiation analyzed by cone-beam computed tomography.

How Much Margin Do We Need for Pelvic Lymph Nodes Irradiation in the Era of IGRT?

Dosimetric feasibility on hypofractionated intensity-modulated radiotherapy and simultaneous integrated boost for locally advanced unresectable pancreatic cancer with helical tomotherapy

Image-Guided Respiratory-Gated Lung Stereotactic Body Radiotherapy: Which Target Definition is Optimal?

Pancreatic Cancer Adjuvant Radiotherapy Target Volume Design: Based on the Postoperative Local Recurrence Spatial Location

Image Registration and Target Volume Margins in Cone-Beam Computed Tomography-Guided Intensity-Modulated Radiotherapy for Prostate Cancer

SU-GG-J-109: A Study on Image Guided Radiotherapy Using Cone-Beam Computed Tomography (CBCT) for Head and Neck Cancer IMRT Patient Setup